Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects.
To view a transcript click here then select the transcript tab.
Pas encore de commentaire